Viewing Study NCT06203704


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-25 @ 5:36 PM
Study NCT ID: NCT06203704
Status: COMPLETED
Last Update Posted: 2025-10-28
First Post: 2023-12-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module